食管-话题@MedSci

#食管#

815篇内容 | 2453人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1437697, encodeId=bbea143e697aa, content=<a href='/topic/show?id=0e311010591a' target=_blank style='color:#2F92EE;'>#食管#</a>, objectTitle=J Immunother Cancer：PD-1抑制剂联合化疗新辅助治疗可切除食管鳞状细胞癌患者的疗效, objectType=article, longId=293994, objectId=aefe293994fa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aefe293994fa, replyNumber=0, likeNumber=88, createdTime=2022-01-16, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aefe293994fa, moduleTitle=J Immunother Cancer：PD-1抑制剂联合化疗新辅助治疗可切除食管鳞状细胞癌患者的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aefe293994fa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1437696, encodeId=8998143e696fa, content=<a href='/topic/show?id=0e311010591a' target=_blank style='color:#2F92EE;'>#食管#</a>, objectTitle=鲁智豪教授：2021年食管癌临床治疗进展盘点, objectType=article, longId=293797, objectId=e100293e972b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e100293e972b, replyNumber=0, likeNumber=64, createdTime=2022-01-12, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e100293e972b, moduleTitle=鲁智豪教授：2021年食管癌临床治疗进展盘点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e100293e972b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1437695, encodeId=304f143e69504, content=<a href='/topic/show?id=0e311010591a' target=_blank style='color:#2F92EE;'>#食管#</a>, objectTitle=Gastric Cancer：III期TAGS研究不同年龄亚组分析Trifluridine and tipiracil (曲氟尿苷替匹嘧啶，FTD/TPI)治疗经治转移性胃/胃食管交界处癌(mGC/GEJC)患者的疗效和安全性, objectType=article, longId=293627, objectId=c7ac29362eb8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c7ac29362eb8, replyNumber=0, likeNumber=23, createdTime=2022-01-10, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c7ac29362eb8, moduleTitle=Gastric Cancer：III期TAGS研究不同年龄亚组分析Trifluridine and tipiracil (曲氟尿苷替匹嘧啶，FTD/TPI)治疗经治转移性胃/胃食管交界处癌(mGC/GEJC)患者的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c7ac29362eb8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1437694, encodeId=506d143e69451, content=<a href='/topic/show?id=0e311010591a' target=_blank style='color:#2F92EE;'>#食管#</a>, objectTitle=Eur J Epidemiol：与食管癌风险升高密切相关的的食管病变, objectType=article, longId=293482, objectId=37d8293482e2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=37d8293482e2, replyNumber=0, likeNumber=99, createdTime=2022-01-07, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=37d8293482e2, moduleTitle=Eur J Epidemiol：与食管癌风险升高密切相关的的食管病变, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=37d8293482e2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1437693, encodeId=fa6f143e693c0, content=<a href='/topic/show?id=0e311010591a' target=_blank style='color:#2F92EE;'>#食管#</a>, objectTitle=Ther Adv Med Oncol：韩国大型真实世界数据评估雷莫芦单抗（Ramucirumab）联合紫杉醇作为二线治疗晚期胃或胃食管交界处腺癌患者的疗效(KCSG-ST19-16), objectType=article, longId=293431, objectId=ec882934312f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ec882934312f, replyNumber=0, likeNumber=55, createdTime=2022-01-06, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ec882934312f, moduleTitle=Ther Adv Med Oncol：韩国大型真实世界数据评估雷莫芦单抗（Ramucirumab）联合紫杉醇作为二线治疗晚期胃或胃食管交界处腺癌患者的疗效(KCSG-ST19-16), moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ec882934312f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1437691, encodeId=33d9143e69189, content=<a href='/topic/show?id=0e311010591a' target=_blank style='color:#2F92EE;'>#食管#</a>, objectTitle=Cancer Med：国内多中心随机双盲II期研究表明安罗替尼（Anlotinib）后线治疗较安慰剂改善晚期或转移性食管鳞癌患者的预后, objectType=article, longId=293004, objectId=d88b293004b9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d88b293004b9, replyNumber=0, likeNumber=76, createdTime=2021-12-30, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d88b293004b9, moduleTitle=Cancer Med：国内多中心随机双盲II期研究表明安罗替尼（Anlotinib）后线治疗较安慰剂改善晚期或转移性食管鳞癌患者的预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d88b293004b9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1437690, encodeId=d58e143e6908b, content=<a href='/topic/show?id=0e311010591a' target=_blank style='color:#2F92EE;'>#食管#</a>, objectTitle=BMC Cancer：对于局部晚期食管癌，如cT1N+和cT2Nany，新辅助治疗或辅助治疗更优？, objectType=article, longId=292998, objectId=6f1329299826, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6f1329299826, replyNumber=0, likeNumber=81, createdTime=2021-12-30, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6f1329299826, moduleTitle=BMC Cancer：对于局部晚期食管癌，如cT1N+和cT2Nany，新辅助治疗或辅助治疗更优？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6f1329299826)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1437692, encodeId=3c7d143e6929c, content=<a href='/topic/show?id=0e311010591a' target=_blank style='color:#2F92EE;'>#食管#</a>, objectTitle=Clinical Gastroenterology H: 纤溶酶原激活物抑制剂-1可以作为小儿嗜酸性粒细胞性食管炎食管功能变化的标志物, objectType=article, longId=292994, objectId=2735292994f2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2735292994f2, replyNumber=0, likeNumber=69, createdTime=2021-12-30, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2735292994f2, moduleTitle=Clinical Gastroenterology H: 纤溶酶原激活物抑制剂-1可以作为小儿嗜酸性粒细胞性食管炎食管功能变化的标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2735292994f2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1437689, encodeId=6680143e6896a, content=<a href='/topic/show?id=0e311010591a' target=_blank style='color:#2F92EE;'>#食管#</a>, objectTitle=指南推荐《食管裂孔疝及胃食管反流性疾病腹腔镜下规范化七步法手术操作指南（2021版）》, objectType=article, longId=292713, objectId=17b7292e13d5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=17b7292e13d5, replyNumber=0, likeNumber=46, createdTime=2021-12-26, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=17b7292e13d5, moduleTitle=指南推荐《食管裂孔疝及胃食管反流性疾病腹腔镜下规范化七步法手术操作指南（2021版）》, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=17b7292e13d5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1437688, encodeId=4021143e6889c, content=<a href='/topic/show?id=0e311010591a' target=_blank style='color:#2F92EE;'>#食管#</a>, objectTitle=重磅！2020胃食管反流病专家共识发布，更新要点图表一览, objectType=article, longId=292656, objectId=894f29265697, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=894f29265697, replyNumber=0, likeNumber=82, createdTime=2021-12-25, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=894f29265697, moduleTitle=重磅！2020胃食管反流病专家共识发布，更新要点图表一览, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=894f29265697)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1437687, encodeId=d763143e6871a, content=<a href='/topic/show?id=0e311010591a' target=_blank style='color:#2F92EE;'>#食管#</a>, objectTitle=化繁为简 | 食管裂孔疝及胃食管反流腹腔镜下手术「七步法」, objectType=article, longId=292646, objectId=af1a292646a3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=af1a292646a3, replyNumber=0, likeNumber=86, createdTime=2021-12-25, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=af1a292646a3, moduleTitle=化繁为简 | 食管裂孔疝及胃食管反流腹腔镜下手术「七步法」, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=af1a292646a3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1437686, encodeId=4683143e6864b, content=<a href='/topic/show?id=0e311010591a' target=_blank style='color:#2F92EE;'>#食管#</a>, objectTitle=全球一半的食管癌在中国，这3个吃饭习惯还不改？那你真会玩自己, objectType=article, longId=292516, objectId=515a292516c9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=515a292516c9, replyNumber=0, likeNumber=67, createdTime=2021-12-24, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=515a292516c9, moduleTitle=全球一半的食管癌在中国，这3个吃饭习惯还不改？那你真会玩自己, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=515a292516c9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1437685, encodeId=e024143e68551, content=<a href='/topic/show?id=0e311010591a' target=_blank style='color:#2F92EE;'>#食管#</a>, objectTitle=Barrett食管（巴雷特）如何诊疗，一文囊括！, objectType=article, longId=292220, objectId=402d29222093, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=402d29222093, replyNumber=0, likeNumber=84, createdTime=2021-12-20, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=402d29222093, moduleTitle=Barrett食管（巴雷特）如何诊疗，一文囊括！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=402d29222093)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1437684, encodeId=f2f0143e68438, content=<a href='/topic/show?id=0e311010591a' target=_blank style='color:#2F92EE;'>#食管#</a>, objectTitle=成人食管异物急诊处置专家共识（2020版），12条核心推荐必读！, objectType=article, longId=221849, objectId=b27b2218491d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b27b2218491d, replyNumber=0, likeNumber=70, createdTime=2021-12-12, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b27b2218491d, moduleTitle=成人食管异物急诊处置专家共识（2020版），12条核心推荐必读！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b27b2218491d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1437683, encodeId=620b143e6838f, content=<a href='/topic/show?id=0e311010591a' target=_blank style='color:#2F92EE;'>#食管#</a>, objectTitle=J Clin Oncol：PD-L1低表达的晚期胃或食管腺癌(GEAC)患者免疫检查点抑制剂（ICI）的疗效, objectType=article, longId=221539, objectId=ea642215396a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ea642215396a, replyNumber=0, likeNumber=61, createdTime=2021-12-06, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ea642215396a, moduleTitle=J Clin Oncol：PD-L1低表达的晚期胃或食管腺癌(GEAC)患者免疫检查点抑制剂（ICI）的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ea642215396a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1437682, encodeId=0404143e68260, content=<a href='/topic/show?id=0e311010591a' target=_blank style='color:#2F92EE;'>#食管#</a>, objectTitle=Front Oncol：基于肿瘤大小的Siewert II/III型食管胃交界处腺癌(AEG)患者幽门淋巴结清扫(PLNs)的生存影响, objectType=article, longId=221515, objectId=0df92215158c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0df92215158c, replyNumber=0, likeNumber=68, createdTime=2021-12-05, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0df92215158c, moduleTitle=Front Oncol：基于肿瘤大小的Siewert II/III型食管胃交界处腺癌(AEG)患者幽门淋巴结清扫(PLNs)的生存影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0df92215158c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1437681, encodeId=2d86143e68190, content=<a href='/topic/show?id=0e311010591a' target=_blank style='color:#2F92EE;'>#食管#</a>, objectTitle=食管癌病例分析, objectType=article, longId=221349, objectId=b61a22134988, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b61a22134988, replyNumber=0, likeNumber=64, createdTime=2021-12-02, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b61a22134988, moduleTitle=食管癌病例分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b61a22134988)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1437680, encodeId=3e9d143e680d3, content=<a href='/topic/show?id=0e311010591a' target=_blank style='color:#2F92EE;'>#食管#</a>, objectTitle=Oncologist:化疗难治性食管鳞状细胞癌患者使用apatinib（阿帕替尼）的疗效和安全性：II期临床研究, objectType=article, longId=221311, objectId=7491221311ab, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7491221311ab, replyNumber=0, likeNumber=65, createdTime=2021-12-01, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7491221311ab, moduleTitle=Oncologist:化疗难治性食管鳞状细胞癌患者使用apatinib（阿帕替尼）的疗效和安全性：II期临床研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7491221311ab)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1437679, encodeId=4734143e6797c, content=<a href='/topic/show?id=0e311010591a' target=_blank style='color:#2F92EE;'>#食管#</a>, objectTitle=血清HO－1、CA72－4、SCC－Ag联合检测在食管鳞癌诊断中的价值, objectType=article, longId=221122, objectId=e0be2211227f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e0be2211227f, replyNumber=0, likeNumber=65, createdTime=2021-11-28, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e0be2211227f, moduleTitle=血清HO－1、CA72－4、SCC－Ag联合检测在食管鳞癌诊断中的价值, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e0be2211227f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1437678, encodeId=3a01143e6784a, content=<a href='/topic/show?id=0e311010591a' target=_blank style='color:#2F92EE;'>#食管#</a>, objectTitle=Front Oncol：SMART+顺铂（CDDP）/S1治疗老年食管鳞状细胞癌（ESCC）患者的疗效和安全性, objectType=article, longId=221107, objectId=ae7022110e3c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ae7022110e3c, replyNumber=0, likeNumber=67, createdTime=2021-11-28, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ae7022110e3c, moduleTitle=Front Oncol：SMART+顺铂（CDDP）/S1治疗老年食管鳞状细胞癌（ESCC）患者的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ae7022110e3c)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

食管

2020-05-29

zhouqu_8 (审核中...)

前往app查看评论内容

#食管#

J Immunother Cancer：PD-1抑制剂联合化疗新辅助治疗可切除食管鳞状细胞癌患者的疗效

2022-01-16

zhouqu_8 (审核中...)

前往app查看评论内容

#食管#

鲁智豪教授：2021年食管癌临床治疗进展盘点

2022-01-12

zhouqu_8 (审核中...)

前往app查看评论内容

#食管#

Gastric Cancer：III期TAGS研究不同年龄亚组分析Trifluridine and tipiracil (曲氟尿苷替匹嘧啶，FTD/TPI)治疗经治转移性胃/胃食管交界处癌(mGC/GEJC)患者的疗效和安全性

2022-01-10

zhouqu_8 (审核中...)

前往app查看评论内容

#食管#

Eur J Epidemiol：与食管癌风险升高密切相关的的食管病变

2022-01-07

zhouqu_8 (审核中...)

前往app查看评论内容

#食管#

Ther Adv Med Oncol：韩国大型真实世界数据评估雷莫芦单抗（Ramucirumab）联合紫杉醇作为二线治疗晚期胃或胃食管交界处腺癌患者的疗效(KCSG-ST19-16)

2022-01-06

zhouqu_8 (审核中...)

前往app查看评论内容

#食管#

Cancer Med：国内多中心随机双盲II期研究表明安罗替尼（Anlotinib）后线治疗较安慰剂改善晚期或转移性食管鳞癌患者的预后

2021-12-30

zhouqu_8 (审核中...)

前往app查看评论内容

#食管#

BMC Cancer：对于局部晚期食管癌，如cT1N+和cT2Nany，新辅助治疗或辅助治疗更优？

2021-12-30

zhouqu_8 (审核中...)

前往app查看评论内容

#食管#

Clinical Gastroenterology H: 纤溶酶原激活物抑制剂-1可以作为小儿嗜酸性粒细胞性食管炎食管功能变化的标志物

2021-12-30

zhouqu_8 (审核中...)

前往app查看评论内容

#食管#

指南推荐《食管裂孔疝及胃食管反流性疾病腹腔镜下规范化七步法手术操作指南（2021版）》

2021-12-26

zhouqu_8 (审核中...)

前往app查看评论内容

#食管#

重磅！2020胃食管反流病专家共识发布，更新要点图表一览

2021-12-25

zhouqu_8 (审核中...)

前往app查看评论内容

#食管#

化繁为简 | 食管裂孔疝及胃食管反流腹腔镜下手术「七步法」

2021-12-25

zhouqu_8 (审核中...)

前往app查看评论内容

#食管#

全球一半的食管癌在中国，这3个吃饭习惯还不改？那你真会玩自己

2021-12-24

zhouqu_8 (审核中...)

前往app查看评论内容

#食管#

Barrett食管（巴雷特）如何诊疗，一文囊括！

2021-12-20

zhouqu_8 (审核中...)

前往app查看评论内容

#食管#

成人食管异物急诊处置专家共识（2020版），12条核心推荐必读！

2021-12-12

zhouqu_8 (审核中...)

前往app查看评论内容

#食管#

J Clin Oncol：PD-L1低表达的晚期胃或食管腺癌(GEAC)患者免疫检查点抑制剂（ICI）的疗效

2021-12-06

zhouqu_8 (审核中...)

前往app查看评论内容

#食管#

Front Oncol：基于肿瘤大小的Siewert II/III型食管胃交界处腺癌(AEG)患者幽门淋巴结清扫(PLNs)的生存影响

2021-12-05

zhouqu_8 (审核中...)

前往app查看评论内容

#食管#

食管癌病例分析

2021-12-02

zhouqu_8 (审核中...)

前往app查看评论内容

#食管#

Oncologist:化疗难治性食管鳞状细胞癌患者使用apatinib（阿帕替尼）的疗效和安全性：II期临床研究

2021-12-01

zhouqu_8 (审核中...)

前往app查看评论内容

#食管#

血清HO－1、CA72－4、SCC－Ag联合检测在食管鳞癌诊断中的价值

2021-11-28

zhouqu_8 (审核中...)

前往app查看评论内容

#食管#

Front Oncol：SMART+顺铂（CDDP）/S1治疗老年食管鳞状细胞癌（ESCC）患者的疗效和安全性

2021-11-28

科室
- - 订阅+
  - 更多科室
工具
服务